Outcomes of anesthesia-supported versus endoscopist-driven sedation modalities: a retrospective cohort study

IF 7.5 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Gastrointestinal endoscopy Pub Date : 2025-08-01 Epub Date: 2025-01-27 DOI:10.1016/j.gie.2025.01.024
Guozhen Xie BSc , Maria Estevez MD , Kiyan Heybati BSc , Matthew Vogt MD , Michael Smith MD , Christine Moshe MD , Johanna Chan MD , Vivek Kumbhari MBChB, PhD , Ryan Chadha MD
{"title":"Outcomes of anesthesia-supported versus endoscopist-driven sedation modalities: a retrospective cohort study","authors":"Guozhen Xie BSc ,&nbsp;Maria Estevez MD ,&nbsp;Kiyan Heybati BSc ,&nbsp;Matthew Vogt MD ,&nbsp;Michael Smith MD ,&nbsp;Christine Moshe MD ,&nbsp;Johanna Chan MD ,&nbsp;Vivek Kumbhari MBChB, PhD ,&nbsp;Ryan Chadha MD","doi":"10.1016/j.gie.2025.01.024","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Aims</h3><div>The use of anesthesia has become commonplace in many procedural settings. The goal of this study is to compare sedation modalities used by endoscopists and anesthesiologists in the endoscopy suite, particularly with respect to recovery time and adverse events.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study including adults (≥18 years of age) undergoing outpatient EGD and/or colonoscopy at Mayo Clinic in Jacksonville, Florida between October 1st, 2018 and December 31st, 2022. Cases were classified as using propofol only, propofol ± adjuvants (PA; including dexmedetomidine, ketamine, fentanyl, and midazolam), general anesthesia (GA) with endotracheal tube, or fentanyl/midazolam (FM) only. The primary outcome was length of stay (LOS) in the postanesthesia care unit (PACU), and secondary outcomes included the incidence of postoperative nausea and vomiting (PONV), hypoxemia (Sp<span>o</span><sub>2</sub> risk 90%), bradycardia (heart rate &lt;60 bpm), and escalation of care (hospital admission).</div></div><div><h3>Results</h3><div>The analysis included 56,361 cases. Among patients who received FM sedation, the mean PACU LOS was 52.01, 49.68, and 53.24 minutes for EGD, colonoscopy, and combined procedures, respectively. This was significantly higher than the mean PACU LOS for GA (44.65, 41.41, and 41.92 minutes, respectively), for PA (32.35, 35.75, and 33.42 minutes, respectively), and for propofol (31.63, 32.61, and 33.29 minutes, respectively; <em>P</em> &lt; .0001). Of patients receiving FM, 8.39% experienced bradycardia, 6.12% experienced hypoxia, 0.24% experienced PONV, and 0.05% were hospitalized. These were substantially lower than the rates for other sedation groups, and odds ratios were significantly lower than 1.00 (<em>P</em> &lt; .05) in 30 of 36 comparisons across procedural, sedative, and outcome categories.</div></div><div><h3>Conclusions</h3><div>Sedation achieved with FM correlated with a lower rate of adverse events but a significantly longer PACU LOS compared with propofol, PA, or GA.</div></div>","PeriodicalId":12542,"journal":{"name":"Gastrointestinal endoscopy","volume":"102 2","pages":"Pages 266-274"},"PeriodicalIF":7.5000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastrointestinal endoscopy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0016510725000483","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Aims

The use of anesthesia has become commonplace in many procedural settings. The goal of this study is to compare sedation modalities used by endoscopists and anesthesiologists in the endoscopy suite, particularly with respect to recovery time and adverse events.

Methods

We conducted a retrospective cohort study including adults (≥18 years of age) undergoing outpatient EGD and/or colonoscopy at Mayo Clinic in Jacksonville, Florida between October 1st, 2018 and December 31st, 2022. Cases were classified as using propofol only, propofol ± adjuvants (PA; including dexmedetomidine, ketamine, fentanyl, and midazolam), general anesthesia (GA) with endotracheal tube, or fentanyl/midazolam (FM) only. The primary outcome was length of stay (LOS) in the postanesthesia care unit (PACU), and secondary outcomes included the incidence of postoperative nausea and vomiting (PONV), hypoxemia (Spo2 risk 90%), bradycardia (heart rate <60 bpm), and escalation of care (hospital admission).

Results

The analysis included 56,361 cases. Among patients who received FM sedation, the mean PACU LOS was 52.01, 49.68, and 53.24 minutes for EGD, colonoscopy, and combined procedures, respectively. This was significantly higher than the mean PACU LOS for GA (44.65, 41.41, and 41.92 minutes, respectively), for PA (32.35, 35.75, and 33.42 minutes, respectively), and for propofol (31.63, 32.61, and 33.29 minutes, respectively; P < .0001). Of patients receiving FM, 8.39% experienced bradycardia, 6.12% experienced hypoxia, 0.24% experienced PONV, and 0.05% were hospitalized. These were substantially lower than the rates for other sedation groups, and odds ratios were significantly lower than 1.00 (P < .05) in 30 of 36 comparisons across procedural, sedative, and outcome categories.

Conclusions

Sedation achieved with FM correlated with a lower rate of adverse events but a significantly longer PACU LOS compared with propofol, PA, or GA.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
麻醉支持与内镜驱动镇静方式的结果:一项回顾性队列研究。
背景和目的:麻醉介入在许多手术设置中已经变得司空见惯。本研究的目的是比较内窥镜医师和麻醉师在内窥镜组中使用的镇静方式,特别是在恢复时间和不良事件方面。方法:我们进行了一项回顾性队列研究,包括2018年10月1日至2022年12月31日期间在佛罗里达州杰克逊维尔梅奥诊所接受门诊EGD和/或结肠镜检查的成年人(≥18岁)。病例分为仅使用异丙酚、异丙酚±佐剂(包括右美托咪定、氯胺酮、芬太尼、咪达唑仑)、气管插管全麻或仅使用咪达唑仑/芬太尼。主要结果是麻醉后护理病房(PACU LOS)的住院时间,次要结果包括术后恶心呕吐(PONV)、低氧血症(spo2)的发生率。结果:56,361例纳入分析。在接受咪达唑仑/芬太尼镇静的患者中,EGD、COL和联合手术的PACU LOS平均分别为52.01、49.68和53.24分钟。这明显高于全麻组的44.65、41.41、41.92,异丙酚+佐剂组的32.35、35.75、33.42,以及异丙酚组的31.63、32.61、33.29。结论:与异丙酚、异丙酚+佐剂或全麻组相比,咪达唑仑/芬太尼镇静与较低的不良事件发生率相关,但PACU LOS明显延长。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gastrointestinal endoscopy
Gastrointestinal endoscopy 医学-胃肠肝病学
CiteScore
10.30
自引率
7.80%
发文量
1441
审稿时长
38 days
期刊介绍: Gastrointestinal Endoscopy is a journal publishing original, peer-reviewed articles on endoscopic procedures for studying, diagnosing, and treating digestive diseases. It covers outcomes research, prospective studies, and controlled trials of new endoscopic instruments and treatment methods. The online features include full-text articles, video and audio clips, and MEDLINE links. The journal serves as an international forum for the latest developments in the specialty, offering challenging reports from authorities worldwide. It also publishes abstracts of significant articles from other clinical publications, accompanied by expert commentaries.
期刊最新文献
Long-term outcomes after endoscopic resection for cervical esophageal squamous cell carcinoma A novel robotic arm–assisted endoscopic submucosal dissection platform with augmented traction for gastric neoplasms: a first-in-human prospective pilot study (with videos) Outcomes of submucosal tunneling endoscopic resection for subepithelial tumors in the upper gastrointestinal tract: experience from the United States Endosonography-guided coloenterostomy for palliative management of peritoneal carcinomatosis (with video) Impact of artificial intelligence–assisted colonoscopy on gastroenterology fellow performance: a pragmatic randomized controlled trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1